11-2133087-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000612.6(IGF2):c.443C>T(p.Ala148Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000311 in 1,607,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A148E) has been classified as Likely benign.
Frequency
Consequence
NM_000612.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF2 | NM_000612.6 | c.443C>T | p.Ala148Val | missense_variant | 4/4 | ENST00000416167.7 | NP_000603.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF2 | ENST00000416167.7 | c.443C>T | p.Ala148Val | missense_variant | 4/4 | 1 | NM_000612.6 | ENSP00000414497.2 | ||
IGF2 | ENST00000381392.5 | c.452C>T | p.Ala151Val | missense_variant | 4/4 | 1 | ENSP00000370799.1 | |||
IGF2 | ENST00000381406.8 | c.452C>T | p.Ala151Val | missense_variant | 4/4 | 2 | ENSP00000370813.4 | |||
ENSG00000284779 | ENST00000643349.2 | c.*495C>T | 3_prime_UTR_variant | 5/5 | ENSP00000495715.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000820 AC: 2AN: 243890Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132616
GnomAD4 exome AF: 0.0000309 AC: 45AN: 1455520Hom.: 0 Cov.: 31 AF XY: 0.0000263 AC XY: 19AN XY: 723466
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74376
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.611C>T (p.A204V) alteration is located in exon 5 (coding exon 4) of the IGF2 gene. This alteration results from a C to T substitution at nucleotide position 611, causing the alanine (A) at amino acid position 204 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at